Bangalore

Cryobanks International India a JV between Cryobanks International USA and RJ Corp  founded in 2006. Cryobanks International is a leader in the collection, processing and banking of umbilical cord blood stem cells. Cryobanks International provides a Private Cord Blood Storage Program for expecting families that wish to privately store their baby's precious stem cells and a Public Cord Blood Donation Program for those who prefer to donate.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

About Authors:
AK Hafeez, MA Akheel, A Ashfaque, NK Meera
Dept of Pharmacy Practice,
VIPS,
Bangalore, India

Abstract
Aim: To study the prescribing pattern for the treatment of Dengue in tertiary care hospital in Bangalore.
Methods: A retrospective study was carried on prescribing pattern of drugs for the treatment of dengue in a tertiary care teaching hospital in Bangalore. This study included hundred patients both male and female in the age group of 1 – 70 years, the prescriptions were analysed for the drug therapy given.
Results:The results show that the most commonly prescribed class of drugs were antipyretic (99%), anti-ulcer (95%), antibiotics (69%) and anti emetic (40%). In addition, supplementary treatment was also observed. 100% of suffered population was treated with IV fluids. Since a specific treatment is not available for Dengue, the patients were treated symptomatically.
Conclusion:This survey highlights the demands for a more specific treatment, lest it leads to another epidemic break in the country.

Application are invited from eligible candidates for the selection of a suitable candidate on deputation/short term/contract for a period of 5 years or upto the date of retirement of the incumbent, whichever is earlier, for the post of Director in National Institute of Unani Medicine(NIUM), Bangalore an autonomous organization under the administrative control of the Department of AYUSH, Ministry of Health and Family Welfare, New Delhi in the Pay Scale of Rs.37400-67,000 with Grade Pay of Rs.10000 + NPA and other usual a

Bristol-Myers Squibb Biocon R&D Center (BBRC) is a collaboration between Bristol-Myers Squibb and Syngene International, a subsidiary of the Indian biotechnology major, Biocon. This initiative is intended to help advance Bristol-Myers Squibb's work in discovery and early drug development. The center is expanding its capabilities to clinical biomarkers, toxicology and first-in-human studies.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.